CN105265971A - Weight losing drink for middle-aged men - Google Patents
Weight losing drink for middle-aged men Download PDFInfo
- Publication number
- CN105265971A CN105265971A CN201510578948.XA CN201510578948A CN105265971A CN 105265971 A CN105265971 A CN 105265971A CN 201510578948 A CN201510578948 A CN 201510578948A CN 105265971 A CN105265971 A CN 105265971A
- Authority
- CN
- China
- Prior art keywords
- parts
- fruit
- raw material
- aged male
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 29
- 239000002994 raw material Substances 0.000 claims abstract description 26
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 18
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 18
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 18
- 235000012907 honey Nutrition 0.000 claims abstract description 18
- 244000241872 Lycium chinense Species 0.000 claims abstract description 16
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 16
- 239000009636 Huang Qi Substances 0.000 claims abstract description 15
- 235000013305 food Nutrition 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 235000002837 Acetobacter xylinum Nutrition 0.000 claims description 18
- 241000005787 Cistanche Species 0.000 claims description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- 239000011780 sodium chloride Substances 0.000 claims description 16
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 13
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 13
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 13
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 13
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 13
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 13
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 13
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 13
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 13
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 13
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 13
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 13
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 13
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 13
- 241000830535 Ligustrum lucidum Species 0.000 claims description 13
- 241000222336 Ganoderma Species 0.000 claims description 12
- 238000009835 boiling Methods 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 10
- 244000235858 Acetobacter xylinum Species 0.000 claims description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 9
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 240000000171 Crataegus monogyna Species 0.000 claims 3
- 239000008280 blood Substances 0.000 abstract description 21
- 210000004369 blood Anatomy 0.000 abstract description 20
- 210000003734 kidney Anatomy 0.000 abstract description 18
- 210000004072 lung Anatomy 0.000 abstract description 13
- 210000000952 spleen Anatomy 0.000 abstract description 13
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 10
- 235000005911 diet Nutrition 0.000 abstract description 10
- 230000037213 diet Effects 0.000 abstract description 10
- 230000008901 benefit Effects 0.000 abstract description 8
- 210000002784 stomach Anatomy 0.000 abstract description 8
- 239000003053 toxin Substances 0.000 abstract description 6
- 231100000765 toxin Toxicity 0.000 abstract description 6
- 230000036541 health Effects 0.000 abstract description 5
- 230000011132 hemopoiesis Effects 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 5
- 235000012000 cholesterol Nutrition 0.000 abstract description 4
- 150000002632 lipids Chemical class 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 230000029087 digestion Effects 0.000 abstract description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 2
- 210000005036 nerve Anatomy 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract 5
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 abstract 1
- 241000336291 Cistanche deserticola Species 0.000 abstract 1
- 240000008397 Ganoderma lucidum Species 0.000 abstract 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 206010039424 Salivary hypersecretion Diseases 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 235000004879 dioscorea Nutrition 0.000 abstract 1
- 230000035622 drinking Effects 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 208000026451 salivation Diseases 0.000 abstract 1
- 108700012359 toxins Proteins 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 26
- 230000006870 function Effects 0.000 description 12
- 208000008589 Obesity Diseases 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 11
- 235000020824 obesity Nutrition 0.000 description 11
- 241001092040 Crataegus Species 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 8
- 239000003814 drug Substances 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- -1 coumarin, steroid saponin Chemical class 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 229920002527 Glycogen Polymers 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- 230000035568 catharsis Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 239000004519 grease Substances 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 206010049865 Achromotrichia acquired Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 201000005569 Gout Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 201000001431 Hyperuricemia Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000003177 cardiotonic effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 235000016804 zinc Nutrition 0.000 description 2
- FFDULTAFAQRACT-NYYYOYJKSA-N (-)-syringaresinol O,O'-bis(beta-D-glucoside) Chemical compound COC1=CC([C@H]2[C@H]3[C@H]([C@@H](OC3)C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=C(OC)C=3)CO2)=CC(OC)=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FFDULTAFAQRACT-NYYYOYJKSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- MRIFZKMKTDPBHR-XLOWEYQUSA-N 8-Epiiridotrial glucoside Chemical compound O([C@H]1[C@H]2[C@@H](C(=CO1)C=O)CC[C@H]2C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O MRIFZKMKTDPBHR-XLOWEYQUSA-N 0.000 description 1
- 208000021959 Abnormal metabolism Diseases 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 208000031872 Body Remains Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- MQDZZCJYWRZONM-UHFFFAOYSA-N Cistanoside A Natural products COc1ccc(CCOC2OC(COC3OC(CO)C(O)C(O)C3O)C(OC(=O)C=Cc4ccc(O)c(O)c4)C(OC5OC(C)C(O)C(O)C5O)C2O)cc1O MQDZZCJYWRZONM-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 240000001879 Digitalis lutea Species 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 229930194248 Licoflavone Natural products 0.000 description 1
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropyl alcohol Natural products CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Chemical class CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000021407 appetite control Nutrition 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- MRIFZKMKTDPBHR-UHFFFAOYSA-N boschnaloside Natural products CC1CCC(C(=CO2)C=O)C1C2OC1OC(CO)C(O)C(O)C1O MRIFZKMKTDPBHR-UHFFFAOYSA-N 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000002468 fat body Anatomy 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- USOSNFWVEWONDB-UHFFFAOYSA-N liriodendrin Natural products COc1cc(cc(OC)c1OC2OC(CO)C(O)C(O)C2O)C3OC(C)(C)C4C(OC(C)(C)C34)c5cc(OC)c(OC6OC(CO)C(O)C(O)C6O)c(OC)c5 USOSNFWVEWONDB-UHFFFAOYSA-N 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 208000020442 loss of weight Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 229940118019 malondialdehyde Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 108010071584 oxidized low density lipoprotein Proteins 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229930182487 phenolic glycoside Natural products 0.000 description 1
- 150000007950 phenolic glycosides Chemical class 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001184 polypeptide Chemical class 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Chemical class 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000001671 psychotherapy Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention discloses a weight losing drink for middle-aged men. The weight losing drink consists of the following raw materials in parts by mass: 15-20 parts of Chinese wolfberry fruits, 12-15 parts of Chinese yams, 6-9 parts of ganoderma lucidum, 10-12 parts of cistanche deserticola, 10-12 parts of radix astragali, 8-10 parts of rhizoma polygonati, 8-12 parts of lotus leaves, 10-15 parts of haws, 5-8 parts of fructus ligustri lucidi, 10-15 parts of licorice, and 25-30 parts of honey. The present invention also discloses two preparing methods. The weight losing drink with such a raw material constitution can supplement and benefit qi, supplement kidney and moisten lungs, regulate blood lipids, lower blood sugar and cholesterol, prevent against aging, promote hematopoiesis, expel toxins, remove thick greasiness, and scrape oil and fat, combines supplement with digestion to enhance vitality, is beneficial to body health in a daily drinking, can strengthen spleen and stomach, does not affect diet, can supplement qi and soothe nerves, supplement kidney and moisten lungs, and promote salivation and benefiting qi, is green and astringent in mouthfeel, and moderate in sourness and sweetness, is suitable for the physical needs of middle-aged men, and achieves the efficacy of losing weight while food consuming and body strengthening.
Description
Technical field
The present invention relates to a kind of beverage, particularly relate to a kind of middle-aged male weight-reducing drinks.
Background technology
Fat-reducing is by the behavior reduced for the purpose of the excessive fat of human body, body weight.Refer to use medicine, diet, motion, Chinese medicine meridian; psychotherapy reaches a kind of phenomenon reducing body fat and pile up; all methods of weight-reducing are all directly or indirectly centered by heat; efficiency index is for reducing heat; health indicator for protection basic metabolism, lasting index be appetite control in satiety and satisfaction.
Current medical science viewpoint, it is disease that obesity is not really, and is but the common worry of many people.There are many ways of preventing obesities on the market, such as, keep fit through sport, but be not all effective to everyone.Some people has successfully deducted fat meat, and spirit is eased up soon, and people is fat again to go back.
Medical research is thought simultaneously, when inside of human body lacks a kind of material of green light element by name, the adjustment of blood sugar for human body, fat and energy can be caused disorderly, then bring out and cause fat; When the green light plain concentration in human body remains on normal level, the body weight of people just recovers normal.
It seems from these phenomenons, the pathological study of obvious modern medicine to obesity does not also really put Chu in order.When the understanding of modern medicine to obesity is human nutrition surplus, health can unnecessary depot fat subcutaneous, so just cause obesity, namely the fat material increased is fat, is a kind of energy be stored.
Present stage, the fat number of middle-aged male gets more and more, serious have impact on is healthy, existing fat-reducing mode is mainly gone on a diet or is strengthened taking exercise, but effect is unsatisfactory, goes on a diet and easily cause malnutrition and actual bodily harm, particularly for the people of obesity, suddenly go on a diet, injury obviously; And the people trained down for obesity is an extremely painful thing, and very easily rebound.
Summary of the invention
The object of the invention is to overcome deficiency of the prior art, provide one to drink mouthfeel good, do not affect diet, there is strong muscle and be healthy and strong, kidney tonifying moistening lung, promoting production of body fluid and benefiting qi middle-aged male weight-reducing drinks.
For achieving the above object, the technology used in the present invention means are: a kind of middle-aged male weight-reducing drinks, and raw material is by following mass parts: the fruit of Chinese wolfberry 15 ~ 20, Chinese yam 12 ~ 15, glossy ganoderma 6 ~ 9, saline cistanche 10 ~ 12, the Radix Astragali 10 ~ 12, sealwort 8 ~ 10, lotus leaf 8 ~ 12, hawthorn 10 ~ 15, the fruit of glossy privet 5 ~ 8, Radix Glycyrrhizae 10 ~ 15, honey 25 ~ 30 form.
Further, in described raw material, the fruit of Chinese wolfberry, Chinese yam, glossy ganoderma, saline cistanche, the Radix Astragali, sealwort, lotus leaf, hawthorn, the fruit of glossy privet, Radix Glycyrrhizae are placed in baking oven, design temperature 65 ~ 75 DEG C oven dry, and taking-up is placed in food masher and pulverizes, and obtain pulverizing raw material for standby.
Further, get pulverize raw material put into take up boiled after naturally cool to the container of the boiling water of 92 ~ 95 DEG C, boil in a covered pot over a slow fire to water temperature Temperature fall to 42 ~ 50 DEG C, add honey, stir, at once drink.
Further, described pulverizing raw material adds tealeaves when putting into container.
Further, in described raw material, the fruit of Chinese wolfberry, Chinese yam, glossy ganoderma, saline cistanche, the Radix Astragali, sealwort, lotus leaf, hawthorn, the fruit of glossy privet, Radix Glycyrrhizae add water, 35 ~ 38 DEG C are naturally cooled to after boiling boiling, add honey, after stirring, add Bayer combining yeast bacterium and acetobacter xylinum, keep temperature 28 ~ 32 DEG C of sealed fermenting 3 ~ 5d, after fermentation ends, cross leaching filtrate and get final product.
Further, described in the mass parts 100 ~ 120 that adds water, the mass parts adding Bayer combining yeast bacterium and acetobacter xylinum is 0.02 ~ 0.04.
Further, described Bayer combining yeast bacterium and acetobacter xylinum combine according to the mass parts of 1:1.
Beneficial effect of the present invention is: raw material is formed with tonifying Qi help, kidney tonifying moistening lung, adjusting blood lipid, reduction blood sugar and cholesterol, anti-ageing, promote hematopoiesis, toxin expelling, go thick greasy, scrape grease, adopt benefit to disappear combination, raising vigor, dailyly drink body health benefits, strengthening the spleen and stomach, do not affect diet, invigorating qi for tranquilization, kidney tonifying moistening lung, promoting production of body fluid and benefiting qi, mouthfeel is not mature sour-sweet moderate, is applicable to the psychological need of middle-aged male, reaches effect of fat-reducing while diet body-building.
Detailed description of the invention
Below in conjunction with embodiment, further statement is done to the present invention.
embodiment 1
A kind of middle-aged male weight-reducing drinks, raw material is by following mass parts: the fruit of Chinese wolfberry 18, Chinese yam 14, glossy ganoderma 8, saline cistanche 11, the Radix Astragali 11, sealwort 9, lotus leaf 10, hawthorn 13, the fruit of glossy privet 6, Radix Glycyrrhizae 14, honey 28 form.
In described raw material, the fruit of Chinese wolfberry, Chinese yam, saline cistanche, the Radix Astragali, sealwort, lotus leaf, hawthorn, the fruit of glossy privet, Radix Glycyrrhizae are placed in baking oven, design temperature 65 ~ 75 DEG C oven dry, and taking-up is placed in food masher and pulverizes, and obtain pulverizing raw material for standby.
Get pulverize raw material put into take up boiled after naturally cool to the container of the boiling water of 92 ~ 95 DEG C, boil in a covered pot over a slow fire to water temperature Temperature fall to 42 ~ 50 DEG C, add honey, stir, at once drink.
Pulverizing raw material gauze according to the hobby of oneself, can pack, makes the pattern of tea in bag class by we, repeatedly adopts aforesaid way to brew.
During operation, we can water is boiled after, in the kettle of heating up water, naturally cool about 3 minutes, water temperature naturally cools to 92 ~ 95 DEG C, is poured into by boiling water in teapot or water tumbler, pulverizing raw material is put into, cover lid makes its Slow cooling, and Temperature fall to 42 ~ 50 DEG C add honey, stir, at once drink.The optimum water temperature drunk is about 40 degree, and when temperature is lower than 37 degree, drug effect can decline.
Drink the sweet perfume (or spice) of sweet mouthfeel and slightly in puckery.Tealeaves can be put into when boiling water is poured in teapot or water tumbler according to individual taste, mouthfeel is better, better to fat-reducing effect, but because there are many people not have tea leaf, does not therefore add tealeaves in the feed.
embodiment 2
A kind of middle-aged male weight-reducing drinks, raw material is by following mass parts: the fruit of Chinese wolfberry 18, Chinese yam 13, glossy ganoderma 7, saline cistanche 11, the Radix Astragali 11, sealwort 9, lotus leaf 11, hawthorn 13, the fruit of glossy privet 7, Radix Glycyrrhizae 13, honey 30 form.
In described raw material, the fruit of Chinese wolfberry, Chinese yam, saline cistanche, the Radix Astragali, sealwort, lotus leaf, hawthorn, the fruit of glossy privet, Radix Glycyrrhizae add water, 35 ~ 38 DEG C are naturally cooled to after boiling boiling, add honey, after stirring, add Bayer combining yeast bacterium and acetobacter xylinum, keep temperature 28 ~ 32 DEG C of sealed fermenting 3 ~ 5d, after fermentation ends, cross leaching filtrate and get final product.
The described mass parts 100 ~ 120 added water, the mass parts adding Bayer combining yeast bacterium and acetobacter xylinum is 0.02 ~ 0.04.Described Bayer combining yeast bacterium and acetobacter xylinum combine according to the mass parts of 1:1.
In the present embodiment, namely honey be active ingredient, plays the function regulating blood, catharsis and toxin expelling, again as fermentation energy.
embodiment 3
Be with embodiment 1 or 2 difference: raw material is by following mass parts: the fruit of Chinese wolfberry 15, Chinese yam 12, glossy ganoderma 6, saline cistanche 10, the Radix Astragali 10, sealwort 8, lotus leaf 8, hawthorn 10, the fruit of glossy privet 5, Radix Glycyrrhizae 10, honey 25 form.Its preparation method adopts the method for embodiment 1 or 2.
embodiment 4
Be with embodiment 1 or 2 difference: raw material is by following mass parts: the fruit of Chinese wolfberry 20, Chinese yam 15, glossy ganoderma 9, saline cistanche 12, the Radix Astragali 12, sealwort 10, lotus leaf 12, hawthorn 15, the fruit of glossy privet 8, Radix Glycyrrhizae 15, honey 30 form.Its preparation method adopts the method for embodiment 1 or 2.
The fruit of Chinese wolfberry: strengthen the body resistance to consolidate the constitution and the timid heresy of righting, not only strengthen body function, promotion health recovers, and can improve the resistance against diseases of body, resists the infringement of disease and evil.Strengthen body to the adaptive capacity of various destructive stimulus.Have obvious inhibitory action to the generation of cancer cell and diffusion, the blurring of vision that treatment deficiency of liver-blood, deficiency of kidney-YIN cause and yctalopia, significantly can increase the stockage of muscle glycogen, hepatic glycogen, improve human activity, have the effect of antifatigue.Improve the function of brain, strengthen the ability of learning and memory of people.Improve the adaptability defense function of human body, when making people run into noxious stimulation, as run into anoxic, cold, to lose blood etc. restrain oneself ability to bear.Promote the effect of hematopoietic cell proliferation, can Cervical mucus be made, strengthen the hematopoiesis function of human body.Effectively delay senility.Improve the ability that skin absorption oxygen divides, play whitening function.The content of remarkable reduction serum cholesterol and triacylglycerol, alleviates and prevents artery sclerosis, treatment hypertension.The symptoms such as the intestines and stomach caused allergy, arthritis are hemorrhage have mitigation, and these effects realize by regulating endocrine.There is the effect protecting the liver kidney tonifying, fat can be suppressed to deposit in liver cell, and promote hepatocellular new life.The fruit of Chinese wolfberry contains the derivative of guanidine, can reduce blood sugar, can lose weight, treatment of obesity.The active ingredient citric acid betaine of the fruit of Chinese wolfberry has the effect of liver diseases such as treatment chronic hepatitis, cirrhosis etc., has good curative effect.
Chinese yam: taste is sweet, property is put down; Return lung, spleen, kidney channel.Tonifying spleen; Support lung; Reinforce the kidney; Benefit essence.Main splenasthenic diarrhea; The few edema of food; The deficiency syndrome of the lung is coughed and is breathed heavily; Quench one's thirst; Seminal emission; Under band; To suffer from a deficiency of the kidney frequent micturition; External application is controlled carbuncle and is swollen; Scrofula.Be conducive to taste digestion and absorption function, no matter spleen sun loses or stomach-Yin deficiency, all edible.Strong body, the effect of nourishing kidney and replenishing pneuma.The diseases such as deficiency of the kidney seminal emission generally, many, the frequent urination of women leukorrhea, all can take it.Have and fall hypoglycemic effect.Effective prevention blood fat, in the precipitation of vascular wall, prevents cardiovascular diseases.Obtain beneficial will to calm the nerves, the effect of promoting longevity.
Glossy ganoderma: sweet, the micro-hardship of taste, property is put down.Energy benefiting qi and nourishing blood, mental-tranquilization, cough-relieving is flat to be coughed.Glossy ganoderma is containing polysaccharide, protein, several amino acids, polypeptide class, ergosterol, sweet mellow wine, alkaloid, coumarin, steroid saponin, adenine, multiple enzyme, various trace elements.There is anti-aging effects, the immunologic function of body can be strengthened; There is sedation; Eliminate the phlegm, cough-relieving, antiasthmatic effect; There is cardiotonic, can MBF be increased, increase CF, reduce heart stock oxygen demand, strengthen hypoxia-bearing capability; Can blood fat be reduced, regulate blood pressure, protection liver, increasing leukocyte; There is certain antitumor action.
Saline cistanche: sweet, tepor, nontoxic.Tonifying kidney and strengthening yang, benefit essence, ease constipation.Saline cistanche contains a large amount of amino acid, vitamin and mineral money, is greatly conducive to health.In addition, saline cistanche is also containing the composition such as glycoside boschnaloside and glutinous polysaccharide; Containing phenylpropyl alcohol glycosyl glycoside cistanoside A, B, C, H, Syring vulgaris phenolic glycoside, Liriodendrin, and 7 kinds of benzyl carbinol glycosides compositions; Containing the material of similar stosterone and estradiol sample; Potassium, sodium, calcium, zinc, manganese, copper etc. are had containing inorganic matter and trace element.Saline cistanche can increase glycogen deposit, reduces muscle after exercise breaks down proteins, impels mitochondria generation adaptability hypertrophy and hyperplasia, to meet the energy required for contraction of muscle and rehabilitation.The synthesis level of RNA and DNA in deficiency of yang Animal Liver spleen can be significantly improved, have yang deficiency syndrome and significantly strengthen muscle power, antifatigue effect.
The Radix Astragali: the sweet temperature of property, returns lung channel, has tonifying Qi and lifting yang, function that benefit defends solid table.Have enhanced machine body immunity function, protect the liver, diuresis, anti-ageing, resisting stress, step-down and antibacterial action more widely.Jishengshenqiwan albuminuria can be eliminated, strengthen myocardial contractive power, regulate blood-sugar content.The Radix Astragali can not only coronary artery dilator, improves myocardial blood supply, improves immunologic function, and can the process of delaying cell aging.
Sealwort: taste is sweet, property is put down, and nourshing kidney moistening lung, invigorates the spleen and benefits qi.Containing asparatate, digitalis glucoside, anthraquinone analog compound, mucilaginous substance, carbohydrate, nicotinic acid, zinc, copper, iron.There are anti anoxia, antifatigue, anti-aging effects; Can immunologic function be strengthened, strengthen metabolism; There is hypoglycemic and cardiotonic.For the lung-dryness syndrome due to yin deficiency, dry cough phlegm is few; Quench one's thirst and drink more; Weakness of the spleen and the stomach, Spleen-Qi Deficiency or deficiency of spleen-YIN; Deficiency of kidney essence, soreness and weakness of waist and knees, poliosis.Inhibitory action is had to typhoid bacillus, staphylococcus aureus, acid-fast bacilli.The blood sugar caused adrenaline is too high in remarkable inhibitory action; Antiviral.
Lotus leaf: bitter is pungent micro-puckery, cool in nature, the thoughts of returning home, liver, the spleen channel; Delicate fragrance rises loose; Have summer heat relieving and dampness eliminating, invigorating the spleen rises sun, effect of loose stasis of blood hemostasis; Nuciferine is the alkaloid extracted in lotus leaf, the expansible blood vessel of Nuciferine, and clearing away summerheat, has hypotensive effect.Lotus leaf is the food of " medicine-food two-purpose ", the Flavonoid substances be rich in lotus leaf, it is the scavenger of most of oxygen radical, SOD(superoxide dismutase can be improved) vigor, reduce MDA(malondialdehyde) and 0X-LDL(OxLDL ELISA) generation, it can increase coronary flow, has antagonism to Myocardial Infarction; Protective effect is had to acute myocardial ischemia; Remarkable result is had to treatment coronary heart disease, hypertension etc.; To reduction diastolic pressure, prevent and treat arrhythmia cordis, cardiovascular disease etc. and also play an important role.Alkaloid in lotus leaf has effect for reducing blood fat, forms one deck fat barrier film, effectively stop the absorption of fat, fundamentally loss of weight after taking on human body intestines wall, and more effective control bounce-back.
Hawthorn: block containing the substance such as vitamin C, carrotene and reduce the generation of free radical, the immunity of body can be strengthened, having anti-aging, anticancer effect; Body fat can be eliminated, reduce fat absorption, U.S. face weight reducing.Have step-down, lipopenicillinase, anti-oxidant, develop immunitypty, removes intestines and stomach harmful bacteria etc., also can prevent liver cancer.Can significantly reduce serum cholesterol and triglycerides, effectively prevent and treat atherosclerotic; Also play cardiac stimulant by strengthening myocardial contractive power, increase cardiac output, coronary artery dilator blood vessel, increase CF, reduction MCO etc. and prevent anginal effect.In addition, the effect of hemangiectasis and lasting step-down is had.Having the effect activated blood circulation and dispersed blood clots, is the dietotherapy good merchantable brand of blood stasis type dysmenorrhoea patient.
The fruit of glossy privet: taste is sweet, bitter, cool in nature; Return liver, kidney channel; Effect: tonifying liver kidney yin, the improving eyesight of crow palpus, suppresses helicobacter pylori, can treat stomach trouble, also has and suppresses purine abnormal metabolism for gout and hyperuricemia.Cure mainly: for the deficiency of liver-yin and kidney-yin, soreness of waist tinnitus, poliosis; Unseeing, poor vision; Fever due to yin deficiency, stomach trouble and gout and and hyperuricemia.
Radix Glycyrrhizae: property is put down, and taste is sweet, returns 12 warps; There is removing toxic substances, eliminate the phlegm, pain relieving, spasmolysis is so that the pharmacological action such as anticancer.Invigorate the spleen and benefit qi, grow and cough moistening lung, emergency is detoxified, and is in harmonious proportion hundred medicines.Raw with curing mainly abscess of throat, pain subcutaneous ulcer sore, gastrointestinal ulceration and antidote poison, food poisoning etc.; Honey is processed and is cured mainly spleen and stomach function and go down, and large loose stool is thin, weak heating and cough, palpitaition etc.Inhibitory action is had to the gastroxia that histamine causes; And have antiacid and alleviate the effect of gastrointestinal smooth muscle spasm.Licoflavone, extract of licorice root and enoxolone all have obvious antitussive effect; Phlegm-dispelling functions is also more remarkable.Also have anti-inflammatory, anti-allergic effects, can protect throat and the tunica mucosa tracheae of inflammation.Containing glycyrrhizin in Radix Glycyrrhizae, be a kind of compound of similar hormone, it contributes to the hormone-content in balanced body.Hypo acid contained by Radix Glycyrrhizae can block the effect of Induced by Carcinogen tumor growth.
Honey: the composition that can improve blood, promotes heart and brain and vascular function, has protective effect, can impel liver cell regeneration to liver, is formed with certain inhibitory action to fatty liver.Edible honey can regain one's strength of body rapidly, and dispelling fatigue builds up one's resistance to disease.Also have the effect of sterilization, not only without prejudice to tooth, the effect of sterilizing can also be played in oral cavity, the skin damage of moderate can be treated, particularly scald, have regulating action to gastrointestinal function, gastric acid secretion can be made normal, strengthen the effect of enterocinesia, significantly can shorten defecation time.
For the understanding of obesity, inventor finds, form fat people and have Symptoms such as breathing hard, lazyness is dynamic, what embody with it at middle-aged male is weak, and sexual demand disappears, obesity complication, therefore, what inventor created employs raw material of the present invention, to the leading nourishing of human body, and blood-enrich, catharsis and toxin expelling; With help toxin expelling, improve physical function, adjusting blood lipid, reduction blood sugar and cholesterol, promote hematopoiesis, go thick greasy, to scrape grease be main, adopts benefit to disappear combination, dailyly drinks body health benefits, strengthening the spleen and stomach, do not affect diet, toxin-expelling and face nourishing, kidney tonifying moistening lung, promoting production of body fluid and benefiting qi, nutritious, mouthfeel is not mature sour-sweet moderate, be applicable to the psychological need of middle-aged male, while diet body-building, reach effect of fat-reducing.
Inventor thinks, fat-reducing must find the basic of problem, can not simple dependence let out or superpower motion, and should nourish the body, regulate on body system function balance and start with, improve physical function, catharsis and toxin expelling, promoting production of body fluid and benefiting qi, kidney tonifying moistening lung, adjusting blood lipid, reduction blood sugar and cholesterol, promote hematopoiesis, go thick greasy, scrape grease, obese people self function is adjusted and digestion, break away from obesity gradually, effectively hale and hearty, instead of become the people become thin, go from one extreme to another.
By analyzing rear discovery, embodiment 1 and embodiment 2 all can reach required effect, but concrete difference is, embodiment 1 is simple to operate, and embodiment 2 operating time is long, and fermentation processes requires high.Embodiment 2 is by after fermentation, and composition can change to some extent, and profitable strain increases, but property of medicine power also can change, and does not find disadvantageous problem according to prior art analysis.Therefore, applicant thinks, the mode of embodiment 1 is more suitable for individual's operation, and embodiment 2 is more suitable for suitability for industrialized production.
The explanation of disclosed embodiment of this invention just to technical solution of the present invention, not as limitation of the present invention, every those skilled in the art on basis of the present invention without creationary replacement, all in protection scope of the present invention.
Claims (7)
1. middle-aged male weight-reducing drinks, is characterized in that: raw material is by following mass parts: the fruit of Chinese wolfberry 15 ~ 20, Chinese yam 12 ~ 15, glossy ganoderma 6 ~ 9, saline cistanche 10 ~ 12, the Radix Astragali 10 ~ 12, sealwort 8 ~ 10, lotus leaf 8 ~ 12, hawthorn 10 ~ 15, the fruit of glossy privet 5 ~ 8, Radix Glycyrrhizae 10 ~ 15, honey 25 ~ 30 form.
2. middle-aged male weight-reducing drinks according to claim 1, it is characterized in that: in described raw material, the fruit of Chinese wolfberry, Chinese yam, glossy ganoderma, saline cistanche, the Radix Astragali, sealwort, lotus leaf, hawthorn, the fruit of glossy privet, Radix Glycyrrhizae are placed in baking oven, design temperature 65 ~ 75 DEG C oven dry, taking-up is placed in food masher and pulverizes, and obtains pulverizing raw material for standby.
3. middle-aged male weight-reducing drinks according to claim 2, it is characterized in that: get pulverize raw material put into take up boiled after naturally cool to the container of the boiling water of 92 ~ 95 DEG C, boil in a covered pot over a slow fire to water temperature Temperature fall to 42 ~ 50 DEG C, add honey, stir, at once drink.
4. middle-aged male weight-reducing drinks according to claim 3, is characterized in that: described pulverizing raw material adds tealeaves when putting into container.
5. middle-aged male weight-reducing drinks according to claim 1, it is characterized in that: in described raw material, the fruit of Chinese wolfberry, Chinese yam, glossy ganoderma, saline cistanche, the Radix Astragali, sealwort, lotus leaf, hawthorn, the fruit of glossy privet, Radix Glycyrrhizae add water, 35 ~ 38 DEG C are naturally cooled to after boiling boiling, add honey, after stirring, add Bayer combining yeast bacterium and acetobacter xylinum, keep temperature 28 ~ 32 DEG C of sealed fermenting 3 ~ 5d, after fermentation ends, cross leaching filtrate and get final product.
6. middle-aged male weight-reducing drinks according to claim 5, is characterized in that: described in the mass parts 100 ~ 120 that adds water, the mass parts adding Bayer combining yeast bacterium and acetobacter xylinum is 0.02 ~ 0.04.
7. middle-aged male weight-reducing drinks according to claim 6, is characterized in that: described Bayer combining yeast bacterium and acetobacter xylinum combine according to the mass parts of 1:1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510578948.XA CN105265971A (en) | 2015-09-14 | 2015-09-14 | Weight losing drink for middle-aged men |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510578948.XA CN105265971A (en) | 2015-09-14 | 2015-09-14 | Weight losing drink for middle-aged men |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105265971A true CN105265971A (en) | 2016-01-27 |
Family
ID=55136477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510578948.XA Pending CN105265971A (en) | 2015-09-14 | 2015-09-14 | Weight losing drink for middle-aged men |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105265971A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106723025A (en) * | 2016-11-30 | 2017-05-31 | 张双标 | A kind of sugared cake of middle-aged male nourishing and preparation method thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1097272A (en) * | 1993-12-03 | 1995-01-18 | 王若浩 | Ganoderma tea |
| CN1156601A (en) * | 1996-02-08 | 1997-08-13 | 袁克兴 | Blood-fat reducing medicine and preparing process thereof |
| JPH10215811A (en) * | 1997-02-07 | 1998-08-18 | Meiji Seika Kaisha Ltd | Food and drink for accelerating combustion of fat |
| CN1481736A (en) * | 2003-08-25 | 2004-03-17 | Healthcare beverage | |
| CN102488274A (en) * | 2011-11-17 | 2012-06-13 | 湖南华人中药科技有限公司 | Botanical beverage and preparation method thereof |
| CN104872774A (en) * | 2015-06-14 | 2015-09-02 | 杜沛雨 | Functional beverage capable of preventing and treating constipation |
-
2015
- 2015-09-14 CN CN201510578948.XA patent/CN105265971A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1097272A (en) * | 1993-12-03 | 1995-01-18 | 王若浩 | Ganoderma tea |
| CN1156601A (en) * | 1996-02-08 | 1997-08-13 | 袁克兴 | Blood-fat reducing medicine and preparing process thereof |
| JPH10215811A (en) * | 1997-02-07 | 1998-08-18 | Meiji Seika Kaisha Ltd | Food and drink for accelerating combustion of fat |
| CN1481736A (en) * | 2003-08-25 | 2004-03-17 | Healthcare beverage | |
| CN102488274A (en) * | 2011-11-17 | 2012-06-13 | 湖南华人中药科技有限公司 | Botanical beverage and preparation method thereof |
| CN104872774A (en) * | 2015-06-14 | 2015-09-02 | 杜沛雨 | Functional beverage capable of preventing and treating constipation |
Non-Patent Citations (1)
| Title |
|---|
| 韦湘林: "复方降脂中药治疗高脂血症述评", 《长春中医学院学报》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106723025A (en) * | 2016-11-30 | 2017-05-31 | 张双标 | A kind of sugared cake of middle-aged male nourishing and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107296949A (en) | Integration of drinking and medicinal herbs compound formulation and its preparation method and application | |
| CN103690783B (en) | Chinese medicine preparation being used for the treatment of diabetes and preparation method thereof | |
| CN106889233A (en) | A kind of bag bubble ginseng Siberian cocklebur bighead atractylodes rhizome tea and preparation method thereof | |
| CN103602551B (en) | Compound traditional Chinese medicinal herbal fermented health-care liquor for promoting digestion and strengthening stomach and production method thereof | |
| CN104225361A (en) | Health wine with radix salviae miltiorrhizae and pseudo-ginseng and preparation method of health wine | |
| CN104083740A (en) | Internal traditional Chinese medicament for gaining weight | |
| CN104286273A (en) | Application of dendrobium candidum and tea leaf product thereof | |
| CN107156828A (en) | A kind of full nutrition formula food suitable for patients with inflammatory bowel | |
| CN103653143A (en) | Health drink for reducing blood pressure and blood fat and preparation method thereof | |
| CN101745087A (en) | Composition with effects of relieving alcoholism and preventing drunkenness and preparation method thereof | |
| CN102100275B (en) | Cassia seed tea | |
| CN105878812A (en) | Hangover-relieving beverage produced using Camellia chrysantha and Caulis dendrobii and production method thereof | |
| CN102511876B (en) | Hawthorn red jujube thick syrup and production process thereof | |
| CN105077501A (en) | Weight-reducing drink for young women | |
| CN106509209A (en) | Propolis health-care tea and preparation method thereof | |
| CN105494781A (en) | Giant knotweed rhizome health care tea for reducing blood glucose and lowering blood lipid | |
| CN108419869A (en) | Fiery composition, beverage and preparation method thereof under a kind of heat-clearing toxin expelling | |
| CN105265971A (en) | Weight losing drink for middle-aged men | |
| CN101062283B (en) | Tea for reducing blood sugar and its preparing method | |
| CN106857937A (en) | A kind of rough gentian flos sophorae and chrysanthemum tea beverage with auxiliary blood pressure reduction effect | |
| CN105077449A (en) | Weight-reducing beverage for male juveniles | |
| CN106387215A (en) | Radix puerariae and cordyceps militaris tea and preparation method thereof | |
| CN105394279A (en) | Lipid-decreasing and weight-losing tea with traditional Chinese medicine added and preparation method of tea | |
| CN114748583A (en) | Traditional Chinese medicine liquor for nourishing and preserving health | |
| CN105455125A (en) | Arillus longan oral solution capable of improving immunity, and preparation method for oral solution |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160127 |
|
| RJ01 | Rejection of invention patent application after publication |